Corp Fin has posted several new or revised CDIs that address exempt solicitations under the proxy rules. With certain exceptions, Rule ...
Inc. (NASDAQ:RCEL), recently acquired 486 shares of the company's common stock. The transaction, dated December 9, 2024, was executed at a price of $13.15 per share, amounting to a total purchase ...
加利福尼亚州瓦伦西亚 - AVITA Medical, Inc. (NASDAQ: RCEL )的董事Suzanne Crowe最近购买了486股公司普通股。这笔交易发生于2024年12月9日,每股价格为13.15美元,总购买价值为6,390美元。此次收购后,Crowe在AVITA ...